ASCENDIS HEALTH LIMITED - Board Consultation Period

Board Consultation Period

Ascendis Health Limited
(Registration number 2008/005856/06)
(Incorporated in the Republic of South Africa)
Share code: ASC
ISIN: ZAE000185005
(“Ascendis Health” or “the Company”)


                                           BOARD CONSULTATION PERIOD


Shareholders are referred to the notice of Annual General Meeting (“AGM”) and to the announcement published on
SENS on 20 December 2021 in which it was confirmed that the Company received a court order compelling the
Company to proceed with the AGM at 09:00.

Shareholders were advised in the circular issued on 3 September 2021 convening the general meeting to approve the
Group Recapitalisation, that in terms of the Company’s senior financing arrangements (as approved pursuant to the
shareholder vote held on 4 October 2021 for the Group Recapitalisation Transaction), any change to the board of
directors of the Company which has not received the prior written approval of the agent (acting on behalf of the lenders)
(“the Agent”) may trigger a cancellation of the debt facilities and may result in such debt facilities becoming immediately
due and payable.

The Company has received a letter from the Agent advising that the prior written approval by the Agent in relation to
any contemplated board changes that may occur at the AGM on 20 December 2021 is not presently in place and the
board will engage with the lenders post the AGM.

20 December 2021
Bryanston

Sponsor
Questco Corporate Advisory Proprietary Limited

Date: 20-12-2021 08:44:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.